Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
Abstract Background Conflicting results has been reported regard osteoporosis and fractures in patients with Differentiated Thyroid Cancer (DTC). Our objective was to evaluate the long‐term effects of TSH suppression therapy with Levothyroxine (LT4) on trabecular bone score (TBS) and bone mineral de...
Main Authors: | Federico Hawkins Carranza, Sonsoles Guadalix Iglesias, María Luisa De Mingo Domínguez, Cristina Martín‐Arriscado Arroba, Begoña López Álvarez, Gonzalo Allo Miguel, Guillermo Martínez Díaz‐Guerra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3200 |
Similar Items
-
Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer
by: Federico Hawkins Carranza, et al.
Published: (2020-12-01) -
The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
by: Arkadiusz Zygmunt, et al.
Published: (2021-10-01) -
Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score
by: Chae Won Chung, et al.
Published: (2021-05-01) -
Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy
by: Bingyu Ran, et al.
Published: (2022-10-01) -
Trabecular bone scores in young HIV-infected men: a matched case-control study
by: Youn Jeong Kim, et al.
Published: (2020-02-01)